The Division of Neuroscience, NIA sponsored this informational meeting to convene experts on neuroimaging in Alzheimer’s disease and mild cognitive impairment (MCI). Attendees represented academia, pharmaceutical companies, imaging companies, NIH program staff, the NIH Office of the Director, the Food and Drug Association, the Alzheimer’s Association, and the Institute for the Study of Aging. Approximately 38 people attended.
